ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Forty Seven’s anti-CD47 combo shows promise in non-Hodgkin lymphoma
November 02, 2018An immunotherapy combining Roche’s blood cancer drug Rituxan and an anti-CD47 drug developed at Stanford University shrank the cancers of half the patients in a small phase 1 trial. -
New Treatment for Non-Hodgkin Lymphoma Approved
August 09, 2018Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma. -
FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma
August 09, 2018Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma.
Pharma Sources Insight January 2025
